Please login to the form below

Not currently logged in
Email:
Password:

NPS

This page shows the latest NPS news and features for those working in and with pharma, biotech and healthcare.

Moderna’s COVID-19 vaccine offers high levels of protection for adolescents

Moderna’s COVID-19 vaccine offers high levels of protection for adolescents

19. This definition requires only one COVID-19 symptom and a nasopharyngeal (NP) swab or saliva sample that tests positive for SARS-CoV-2 by RT-PCR.

Latest news

More from news
Approximately 3 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • The flexible salesforce The flexible salesforce

    Interestingly, across all the countries mentioned above there has been no drop-off in the positive NPS for F2F, despite much lower activity and increased use of other channels. ... Germany also has a stable positive NPS at 35% and has seen F2F visits

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    As many of the safety and manufacturing issues surrounding our MVA-NP M1 vaccine are already de-risked, a positive efficacy readout in the challenge study should allow us to take

  • Digital mania - a question of value Digital mania - a question of value

    So bad in fact, that the best Net Promoter Score (NPS) is a whopping -40% (minus!).

  • A rare talent A rare talent

    Before that the firm had a busy 2015, buying US rare disease-focused biotech NPS Pharma for $5.2bn and rare disease and gastrointestinal company Meritage Pharma for at least $70m

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    NPS/Shire. NPS specialises in rare diseases including Gattex [teduglutide] for the treatment of short bowel syndrome.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Prevail Therapeutics adds to its board of directors Prevail Therapeutics adds to its board of directors

    From 2008-2015 Nader was president and chief executive officer of NPS Pharma, until Shire acquired the company for $5.2bn. ... Before his time at NPS, Nader was a venture partner at Care Capital and he also previously served on the North America

  • CRISPR Therapeutics appoints Dr Tony Coles CRISPR Therapeutics appoints Dr Tony Coles

    He has also previously held executive and leadership positions at NPS Pharmaceuticals, Vertex Pharmaceuticals, Bristol-Myers Squibb and Merck &Co.

  • Patrick Fabbio named CFO at electroCore Patrick Fabbio named CFO at electroCore

    He joins from NPS Pharmaceuticals where he was VP finance. US-based electroceutical healthcare company electroCore has named Patrick Fabbio as chief financial officer. ... Fabbio has over 20 years of financial leadership experience in public and private

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

Partnering with Patients and Caregivers in Clinical Research
...
Practical advice for Early Scientific Advice (ESA) in HTA submissions
A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence...
Jonathan Cooke
The fight against antimicrobial resistance
By Jonathan Cooke...